Edwards Lifesciences Corp.
(NYSE : EW)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
0.59%486.422.4%$461.23m
TMOThermo Fisher Scientific Inc.
2.54%272.111.0%$437.55m
MDTMedtronic PLC
1.36%88.970.6%$420.19m
BDXBecton, Dickinson and Company
0.98%236.271.1%$380.24m
ABTAbbott Laboratories
0.55%76.450.8%$377.09m
ALGNAlign Technology, Inc.
-0.09%319.406.3%$355.75m
BSXBoston Scientific Corporation
0.25%37.801.1%$317.37m
ABMDABIOMED, Inc.
2.32%266.383.3%$263.95m
SYKStryker Corporation
0.31%186.021.3%$219.79m
BAXBaxter International Inc.
0.52%75.691.7%$199.63m
EWEdwards Lifesciences Corporation
0.49%172.841.2%$194.50m
WATWaters Corporation
0.70%207.603.8%$158.91m
ZBHZimmer Biomet Holdings, Inc.
-0.61%115.401.7%$147.12m
DXCMDexCom, Inc.
0.07%118.678.3%$128.82m
IDXXIDEXX Laboratories, Inc.
0.67%250.993.7%$123.92m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..